StonvexLoading…
StonvexStonvexStonvexCore line items from BTBD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-29 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 | Q1 2025 2025-03-30 |
|---|---|---|---|---|
Revenue | $2.84M | $10.86M | $7.01M | $3.23M |
Operating Income | $-232.81K | $367.73K | $-367.32K | $-292.20K |
Net Income | $-751.01K | $640.16K | $-274.82K | $-329.85K |
EPS (Diluted) | $-0.12 | $0.10 | Not available | $-0.05 |
Total Assets | $9.98M | $11.94M | $11.22M | $11.00M |
Total Liabilities | $4.30M | $4.21M | $4.43M | $4.34M |
Cash & Equivalents | $1.01M | $1.28M | $560.07K | $1.07M |
Free Cash Flow OCF − CapEx | $-137.76K | $215.03K | $-46.74K | $-431.10K |
Shares Outstanding | 6.15M | 6.15M | 6.15M | 6.15M |